Conference abstractPublished 2016
Pharmacotherapy 2016: An update and review of anti-obesity medications for adults and emerging concepts for pediatrics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
As the obesity epidemic continues to grow, clinicians need to take a comprehensive approach to treat patients, addressing nutrition, physical activity, behavior, and pharmacologic intervention. Several new anti-obesity medications have been developed over the past 4 years, and multiple treatment algorithms and guidelines have been released. This presentation will review the indications and practical selection of various medications based on patient profiles, mechanisms of action, and underlying comorbidities. Recent studies evaluating possible combination therapy will also be discussed. Although the newer anti-obesity agents have only been approved for adults, potential therapeutic options for children will be presented as well. Several cases will be used to illustrate practical techniques for adjustment of patients' medications for other conditions, proper anti-obesity medication selection, and drug monitoring to maximize patients' results and long-term success.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diabetes & Metabolism
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Yazen Joudeh”